Eva Kaergel

443 total citations
7 papers, 271 citations indexed

About

Eva Kaergel is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Cancer Research. According to data from OpenAlex, Eva Kaergel has authored 7 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Biochemistry and 3 papers in Cancer Research. Recurrent topics in Eva Kaergel's work include Eicosanoids and Hypertension Pharmacology (3 papers), NF-κB Signaling Pathways (3 papers) and Hormonal Regulation and Hypertension (3 papers). Eva Kaergel is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (3 papers), NF-κB Signaling Pathways (3 papers) and Hormonal Regulation and Hypertension (3 papers). Eva Kaergel collaborates with scholars based in Germany, Switzerland and Japan. Eva Kaergel's co-authors include Wolf‐Hagen Schunck, Friedrich C. Luft, Horst Honeck, Dominik N. Müller, Erdenechimeg Shagdarsuren, Michael Hummel, Anette Fiebeler, Claus Scheidereit, Hermann Haller and Joon-Keun Park and has published in prestigious journals such as Blood, Kidney International and Hypertension.

In The Last Decade

Eva Kaergel

7 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Kaergel Germany	5	121	79	74	68	66	7	271
Jessica A. Wray United Kingdom	5	167 1.4×	87 1.1×	46 0.6×	167 2.5×	35 0.5×	8	345
Yaogui Ning China	8	120 1.0×	58 0.7×	24 0.3×	85 1.3×	66 1.0×	19	328
Alvin Jogasuria United States	11	56 0.5×	62 0.8×	139 1.9×	157 2.3×	75 1.1×	12	398
Liliane K. Yacoub United States	8	75 0.6×	199 2.5×	104 1.4×	217 3.2×	110 1.7×	8	642
Jacqueline Williams Australia	8	38 0.3×	142 1.8×	47 0.6×	142 2.1×	31 0.5×	8	475
Christopher McPhaul United States	4	110 0.9×	232 2.9×	61 0.8×	101 1.5×	24 0.4×	6	552
Filomena Campagna Italy	12	82 0.7×	132 1.7×	24 0.3×	163 2.4×	90 1.4×	13	604
Catriona McNeil United Kingdom	10	42 0.3×	137 1.7×	19 0.3×	126 1.9×	33 0.5×	13	477
Torsten Hoff Germany	7	56 0.5×	59 0.7×	10 0.1×	83 1.2×	43 0.7×	11	408

Countries citing papers authored by Eva Kaergel

Since Specialization

Citations

This map shows the geographic impact of Eva Kaergel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kaergel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kaergel more than expected).

Fields of papers citing papers by Eva Kaergel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Kaergel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kaergel. The network helps show where Eva Kaergel may publish in the future.

Co-authorship network of co-authors of Eva Kaergel

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Kaergel. A scholar is included among the top collaborators of Eva Kaergel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Kaergel. Eva Kaergel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Kaergel, Eva, Matthias Heinig, Jean−Fred Fontaine, et al.. (2016). A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses. Genome Medicine. 8(1). 28–28. 47 indexed citations

2.

Nogai, Hendrik, Stephan Hailfinger, Michael Grau, et al.. (2013). IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. Blood. 122(13). 2242–2250. 59 indexed citations

3.

Nogai, Hendrik, Stephan Hailfinger, Michael Grau, et al.. (2013). I{kappa}B-{zeta} controls the constitutive NF-{kappa}B target gene network and survival of ABC DLBCL. 4 indexed citations

4.

Shagdarsuren, Erdenechimeg, Dominik N. Müller, Eva Kaergel, et al.. (2004). Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II–induced renal damage. Kidney International. 67(1). 248–258. 22 indexed citations

5.

Müller, Dominik N., Erdenechimeg Shagdarsuren, Eva Kaergel, et al.. (2004). A Peroxisome Proliferator-Activated Receptor-α Activator Induces Renal CYP2C23 Activity and Protects from Angiotensin II-Induced Renal Injury. American Journal Of Pathology. 164(2). 521–532. 80 indexed citations

6.

Kaergel, Eva, Dominik N. Müller, Horst Honeck, et al.. (2002). P450-Dependent Arachidonic Acid Metabolism and Angiotensin II–Induced Renal Damage. Hypertension. 40(3). 273–279. 55 indexed citations

7.

Kaergel, Eva, Yuri Aoyama, Wolf‐Hagen Schunck, H.‐G. MUELLER, & Yuichi Yoshida. (1990). Comparative study on cytochrome P‐450 of yeasts using specific antibodies to cytochromes P‐450_alk and P‐450_14DM. Yeast. 6(1). 61–67. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact